See everything published about Linneo Health
Linneo Health and Phytocontrol Group sign an exclusive medicinal cannabis clinical analysis collaboration agreement
Agreement gives Linneo Health access to Phytocontrol’s leading clinical analysis...
Linneo Health awarded EU Good Manufacturing Practice (GMP) Part I license
Certification further expands existing offering, enabling Linneo Health to manufacture finished dosage...
Linneo Health expands medicinal cannabis offering to include industrial cannabis derivatives, following the issuing of EU-GMP certification to Alcaliber's industrial facility
Linneo Health to expand offering of medicinal cannabis products to include APIs...
Linneo Health appoints Gerardo Gorostiza as Chief Financial and Strategy Officer
Linneo Health, a global header in the research, cultivation and supply of cannabis to improve human health and wellbeing, today announces the appointment of Gerardo Gorostiza as Chief Financial and Strategy Officer...
Linneo Health awarded grant to research and cultivate differentiated cannabis strains
€200,000 grant from ICEX, Invest in Spain and European Regional Development Fund will support ongoing CANNABI+ project developing cannabis varieties with unique cannabinoid and terpene profiles
Linneo Health announces GMP certification of quality control laboratory by AEMPS
Linneo Health announces GMP certification of quality control laboratory by AEMPS – Company holds one of the most advanced cannabis quality control laboratories in Europe.- Certification provides unrivalled offering to partners
Linneo Health appoints Don Bellany as Chief Executive Officer
Experienced executive bringing over 30 years’ pharmaceuticals and regulated cannabis industry knowledge. Madrid, Spain 29 September 2021.
Linneo Health, the first Spanish manufacturing company for medical Cannabis
Linneo Health, the first Spanish manufacturing company for medical Cannabis under GMP accreditation - It is a milestone of extraordinary relevance in the medicinal cannabis industry...